hims semaglutide results & Hers launched a $49 weight loss pill last week, offering a compounded version of semaglutide, the active ingredient in FDA approved drugs like Wegovy. Just 48 hours later, the company Hims expansion may not come

The good news: "No aspiration events, respiratory distress or aspiration pneumonia" occurred among the patients, regardless of whether they'd taken one of the weight-loss treatments or not, the researchers said

Collagen helps in improving the elasticity and firmness of the skin, resulting in a smoother and more youthful appearance

It is currently under regulatory review and is not yet approved for use

The majority of patients experience significant weight regain if treatment with GLP-1 medications stops, and it is unclear if there will be a sustainable, long-term access to GLP-1 treatment for obesity for Medicare beneficiaries. Nielsen says she anticipates demand for the GLP-1 Bridge program will be high, making it important to see your healthcare provider for an evaluation now